Products billed under this code include Abraxane, Paclitaxel Protein-Bound, Paclitaxel Protein-Bound (American Regent), Paclitaxel Protein-Bound Particles.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Abraxane | Celgene Corporation | 68817-0134-50 | 100 | $364.00 |
| Paclitaxel Protein-Bound | American Regent, Inc. | 00517-4300-01 | 100 | $364.00 |
| Paclitaxel Protein-Bound | TWI Pharmaceuticals, Inc. | 24979-0710-51 | 100 | $364.00 |
| Paclitaxel Protein-Bound | Apotex Corp | 60505-6230-04 | 100 | $364.00 |
| Paclitaxel Protein-Bound | BluePoint Laboratories | 68001-0651-37 | 100 | $364.00 |
| Paclitaxel Protein-Bound | Cipla USA, Inc. | 69097-0398-78 | 100 | $364.00 |
| Paclitaxel Protein-Bound | Meitheal Pharmaceuticals Inc. | 71288-0183-50 | 100 | $364.00 |
| Paclitaxel Protein-Bound (American Regent) | Teva Pharmaceuticals USA, Inc. | 00480-3290-01 | 100 | $364.00 |
| Paclitaxel Protein-Bound Particles | Sandoz Inc. | 00781-3531-91 | 100 | $364.00 |
| Paclitaxel Protein-Bound Particles | Mylan Institutional LLC | 67457-0937-50 | 100 | $364.00 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Paclitaxel Protein-Bound Particles | Northstar RxLLC | 72603-0408-01 | 100 | $364.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $3.64 | −$2.946 | 1 MG | Paclitaxel protein bound | v1, posted September 17, 2026 |
| 3Q26 | $6.586 | +$0.566 | 1 MG | Paclitaxel protein bound | v1, posted September 15, 2026 |
| 2Q26 | $6.02 | −$2.164 | 1 MG | Paclitaxel protein bound | v1, posted September 15, 2026 |
| 1Q26 | $8.184 | −$2.359 | 1 MG | Paclitaxel protein bound | v1, posted September 15, 2026 |
| 4Q25 | $10.543 | −$1.579 | 1 MG | Paclitaxel protein bound | v1, posted September 8, 2026 |
| 3Q25 | $12.122 | −$0.942 | 1 MG | Paclitaxel protein bound | v1, posted March 10, 2026 |
| 2Q25 | $13.064 | −$0.472 | 1 MG | Paclitaxel protein bound | v1, posted March 10, 2026 |
| 1Q25 | $13.536 | +$0.192 | 1 MG | Paclitaxel protein bound | v1, posted December 19, 2025 |
| 4Q24 | $13.344 | +$0.104 | 1 MG | Paclitaxel protein bound | v1, posted June 11, 2025 |
| 3Q24 | $13.24 | −$0.474 | 1 MG | Paclitaxel protein bound | v1, posted June 11, 2025 |
| 2Q24 | $13.714 | −$0.58 | 1 MG | Paclitaxel protein bound | v1, posted March 11, 2025 |
| 1Q24 | $14.294 | −$0.491 | 1 MG | Paclitaxel protein bound | v1, posted December 19, 2024 |
| 4Q23 | $14.785 | +$2.729 | 1 MG | Paclitaxel protein bound | v1, posted October 10, 2024 |
| 3Q23 | $12.056 | +$0.272 | 1 MG | Paclitaxel protein bound | v1, posted June 5, 2024 |
| 2Q23 | $11.784 | −$0.191 | 1 MG | Paclitaxel protein bound | v1, posted February 23, 2024 |
| 1Q23 | $11.975 | −$0.215 | 1 MG | Paclitaxel protein bound | v1, posted December 6, 2023 |
| 4Q22 | $12.19 | −$2.503 | 1 MG | Paclitaxel protein bound | v1, posted June 22, 2023 |
| 3Q22 | $14.693 | +$0.506 | 1 MG | Paclitaxel protein bound | v1, posted June 9, 2023 |
| 2Q22 | $14.187 | +$0.143 | 1 MG | Paclitaxel protein bound | v1, posted December 14, 2022 |
| 1Q22 | $14.044 | −$0.033 | 1 MG | Paclitaxel protein bound | v1, posted June 8, 2022 |
| 4Q21 | $14.077 | −$0.027 | 1 MG | Paclitaxel protein bound | v1, posted June 2, 2022 |
| 3Q21 | $14.104 | +$0.757 | 1 MG | Paclitaxel protein bound | v1, posted June 2, 2022 |
| 2Q21 | $13.347 | −$0.084 | 1 MG | Paclitaxel protein bound | v1, posted March 1, 2022 |
| 1Q21 | $13.431 | – | 1 MG | Paclitaxel protein bound | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
